Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review

Autor:	Haily Kil, Ron P. Gallemore, Charlotte Luths, Josh Wallsh
Rok vydání:	2020
Předmět:	medicine.medical_specialty Intraocular pressure Visual acuity genetic structures business.industry Glaucoma medicine.disease eye diseases 03 medical and health sciences Ophthalmology 0302 clinical medicine Central retinal vein occlusion Cohort 030221 ophthalmology & optometry medicine Branch retinal vein occlusion sense organs medicine.symptom business 030217 neurology & neurosurgery Dexamethasone Uveitis medicine.drug
Zdroj:	Clinical Ophthalmology. 14:3097-3108
ISSN:	1177-5483
DOI:	10.2147/opth.s264559
Popis:	Purpose To evaluate the initial ten years of results from the intravitreal dexamethasone implant (DEX) in patients treated for retinal vein occlusion (RVO), diabetic macular edema (DME) or uveitis. Methods Retrospective chart review of patients receiving DEX since its FDA approval. Best-corrected visual acuity (BCVA), central macular thickness (CMT) on optical coherence tomography, intraocular pressure and cataract status were collected. Baseline data were collected from the initial DEX and post-treatment data at the visit at least four weeks after the last DEX. Results In total, 315 eyes received 1216 DEX over 63.9±4.6 weeks. In the branch RVO (n=90), central RVO (n=59) and DME (n=62) cohorts, BCVA improved significantly (p
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8efd26bf29c0c3392af2b6e3c3c97e18 https://doi.org/10.2147/opth.s264559 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.